Management of subclinical hypothyroidism

American Family Physician

Volumn 71, Issue 9, 2005, Pages 1763-1764

  Ibay, Annamarie D ^a   Bascelli, Lynda M ^a   Nashelsky, Joan ^b  

^a West Jersey Memorial Family Practice Residency at Virtua   (United States)

^b Family Practice Inquiries Network   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; PLACEBO; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

CLINICAL TRIAL; HUMAN; HYPOTHYROIDISM; OUTCOMES RESEARCH; RISK FACTOR; SHORT SURVEY; THYROID FUNCTION TEST;

AUTOANTIGENS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HUMANS; HYPOTHYROIDISM; IODIDE PEROXIDASE; IRON-BINDING PROTEINS; SEVERITY OF ILLNESS INDEX; THYROTROPIN; THYROXINE;

EID: 18344376622     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (5)

1. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004;291:228-38.
2. American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 2002;8:457-69.
3. Thyroid hormone replacement for subclinical hypothyroidism (Cochrane Protocol). Accessed online March 24, 2005, at: http://www.mrw.interscience. wiley.com/cochrane/clsysrev/articles/CD03419/pdf_fs.html.
4. Helfend M, U.S. Preventive Services Task Force. Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2004;140:128-41.
5. Kristensen L, Nygaard B. What are the effects of treatments for subclinical hypothyroidism? Clin Evid Concise 2003;9:125-6.